Header image

Session 12B: From Australia to the world: Building global biotech companies without leaving Australia behind

Tracks
Track 2
Friday, October 23, 2026
2:55 PM - 3:40 PM
Investment & Global Growth Breakout Room

Details

Australia consistently produces world-class science, strong early clinical data and globally relevant biotechnology innovation. But as companies grow, success increasingly depends on accessing global capital, talent, partners, manufacturing and markets. So what does it really take to build a globally competitive biotechnology company while retaining meaningful capability in Australia? Bringing together CEOs who have successfully built and led globally connected biotechnology companies, this leadership conversation explores the practical realities of scaling from Australia to the world. Rather than revisiting the familiar narrative of Australia's commercialisation challenges, the discussion focuses on the strategic decisions that shape global success: where companies should build capability, when international partnerships become essential, how leadership evolves as organisations scale, and what Australia must continue to do to remain an attractive place to innovate, invest and grow. Delegates will gain practical insights into building companies that are both proudly Australian and globally competitive.


Speaker

Agenda Item Image
Mrs Cheryl Maley
CEO
Starpharma

Panellist

Agenda Item Image
Miss Sarah Meibusch
Partner & Head Of Healthcare
OneVentures

Chair

Agenda Item Image
Mr Bruce Peatey
CEO
PolyNovo

Panellist

loading